My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions, conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts.
About Us
Plans & Pricing
Pressure Biosciences (PBIO)
PBIO other otc
United States
Pressure Biosciences

Pressure Biosciences Stock Analysis & Ratings

Pressure Biosciences Stock Analysis Overview

Smart Score
Not Ranked
Learn more about TipRanks Smart Score
This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.

Stock Chart


PBIO Stock Stats

Previous Close$2.35
Bid0 x 0
Ask0 x 0
Today’s Range$2.26 - $2.39
52-Week Range$1.45 - $4.98
Average Volume30.11K
Market Cap$17.22M
P/E Ratio-0.6
Earnings DateApr 06, 2022

Company Description

Pressure Biosciences

Pressure BioSciences, Inc. is engagedin the development, marketing, and sale of proprietary laboratory instrumentation and associated consumables. Its products includes high pressure barocyclers and barozyme, high pressure generators and accessories, mini ultra-high pressure pump, barocycler and barozyme accessories, microtube accessories for barocyclers and barozyme, high pressure cell disruptors from constant systems, reagent kits, and service contracts. The firm offers its products under the brands Barocycler, PULSE, BioSeq, ProteoSolve, ProteoSolveLRS, Power of PCT, PCT Shredder, HUB440, HUB880, micro- Pestle, PCT-HD, BaroFold, Barozyme and BaroFlex, Strips,The company was founded by Richard T. Schumacher in August 1978 and is headquartered in South Easton, MA.
Medical Devices & Instruments
Richard T. Schumacher
14 Norfolk Avenue, South Easton, MA, 02375, US


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


What was Pressure Biosciences’s price range in the past 12 months?
Pressure Biosciences lowest stock price was $1.45 and its highest was $4.98 in the past 12 months.
    What is Pressure Biosciences’s market cap?
    Pressure Biosciences’s market cap is $17.22M.
      What is Pressure Biosciences’s price target?
      Currently, no data Available
      What do analysts say about Pressure Biosciences?
      Not enough analysts have published a price target to provide an average price target.
      When is Pressure Biosciences’s upcoming earnings report date?
      Pressure Biosciences’s upcoming earnings report date is Apr 06, 2022 which is in 120 days.
        How were Pressure Biosciences’s earnings last quarter?
        Pressure Biosciences released its earnings results on Nov 17, 2021. The company reported -$0.82 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.82.
          Is Pressure Biosciences overvalued?
          According to Wall Street analysts Pressure Biosciences’s price is currently Overvalued.
            Does Pressure Biosciences pay dividends?
            Pressure Biosciences does not currently pay dividends.
            What is Pressure Biosciences’s EPS estimate?
            Pressure Biosciences’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Pressure Biosciences have?
            Pressure Biosciences has 7,390,000 shares outstanding.
              What happened to Pressure Biosciences’s price movement after its last earnings report?
              Pressure Biosciences reported an EPS of -$0.82 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.353%.
                Which hedge fund is a major shareholder of Pressure Biosciences?
                Currently, no hedge funds are holding shares in PBIO

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis